Clare Sun

2.9k total citations
65 papers, 1.5k citations indexed

About

Clare Sun is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Clare Sun has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Genetics, 26 papers in Pathology and Forensic Medicine and 26 papers in Immunology. Recurrent topics in Clare Sun's work include Chronic Lymphocytic Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Clare Sun is often cited by papers focused on Chronic Lymphocytic Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immunodeficiency and Autoimmune Disorders (17 papers). Clare Sun collaborates with scholars based in United States, Spain and Canada. Clare Sun's co-authors include Adrian Wiestner, Xin Tian, Gerald E. Marti, Janet Valdez, Sarah E. M. Herman, Mohammed Farooqui, Christopher Pleyer, Inhye E. Ahn, Maryalice Stetler‐Stevenson and Nakhle S. Saba and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Clare Sun

61 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clare Sun United States 20 980 686 568 457 292 65 1.5k
Charles Herbaux France 23 1.1k 1.1× 1.2k 1.7× 591 1.0× 675 1.5× 460 1.6× 111 1.9k
Tycel Phillips United States 22 554 0.6× 956 1.4× 367 0.6× 899 2.0× 278 1.0× 149 1.6k
Sophie de Guibert France 18 566 0.6× 640 0.9× 846 1.5× 456 1.0× 321 1.1× 42 1.6k
Jeanette Lundin Sweden 21 1.1k 1.1× 1.1k 1.7× 1.1k 1.9× 544 1.2× 448 1.5× 53 2.2k
P. M. Kluin Netherlands 21 431 0.4× 1.0k 1.5× 314 0.6× 797 1.7× 260 0.9× 40 1.8k
D Filippa United States 21 608 0.6× 969 1.4× 263 0.5× 706 1.5× 297 1.0× 34 1.6k
Michaela Cerri Italy 14 530 0.5× 636 0.9× 253 0.4× 473 1.0× 114 0.4× 27 1.1k
E. Condé Spain 21 452 0.5× 1.1k 1.7× 314 0.6× 943 2.1× 284 1.0× 43 1.7k
Elisabeth Vandenberghe Ireland 26 890 0.9× 891 1.3× 405 0.7× 672 1.5× 1.0k 3.4× 91 2.2k
Eugenia Haralambieva Germany 24 533 0.5× 1.3k 1.8× 370 0.7× 883 1.9× 287 1.0× 52 2.1k

Countries citing papers authored by Clare Sun

Since Specialization
Citations

This map shows the geographic impact of Clare Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Sun more than expected).

Fields of papers citing papers by Clare Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Sun. The network helps show where Clare Sun may publish in the future.

Co-authorship network of co-authors of Clare Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Sun. A scholar is included among the top collaborators of Clare Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Sun. Clare Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chen, Jonathan, Erika M. Gaglione, Chingiz Underbayev, et al.. (2023). CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical Cancer Research. 29(18). 3612–3621. 11 indexed citations
4.
Gaglione, Erika M., John H. Herrick, Inhye E. Ahn, et al.. (2023). Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting. Blood Advances. 7(15). 4089–4101. 27 indexed citations
5.
Collins, McKensie, In-Young Jung, Ziran Zhao, et al.. (2022). Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL. Cancer Research Communications. 2(9). 1089–1103. 11 indexed citations
6.
Sun, Clare, Aina Zurita Martinez, Maria João Baptista, et al.. (2022). The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia. Blood Advances. 7(1). 145–158. 26 indexed citations
7.
Hsu, Li‐Yueh, Clare Sun, Pia Nierman, et al.. (2022). Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic Leukemia. Academic Radiology. 30(6). 1056–1065. 1 indexed citations
8.
Baptista, Maria João, Sivasubramanian Baskar, Erika M. Gaglione, et al.. (2021). Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Clinical Cancer Research. 27(16). 4624–4633. 8 indexed citations
9.
Brown, Jennifer R., John C. Byrd, Paolo Ghia, et al.. (2021). Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients. Haematologica. 107(6). 1335–1346. 26 indexed citations
10.
Sun, Clare & Adrian Wiestner. (2021). Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?. Hematology/Oncology Clinics of North America. 35(4). 827–845. 4 indexed citations
11.
Cheung, Jean, Michael Gulrajani, Erika M. Gaglione, et al.. (2020). Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib. Clinical Cancer Research. 26(12). 2800–2809. 21 indexed citations
12.
Underbayev, Chingiz, Clare Sun, Komudi Singh, et al.. (2019). IKAP—Identifying K mAjor cell Population groups in single-cell RNA-sequencing analysis. GigaScience. 8(10). 13 indexed citations
13.
Lerner, Andrea, John E. Bennett, Stefania Pittaluga, et al.. (2019). Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver. Diagnostic Microbiology and Infectious Disease. 94(2). 180–182. 1 indexed citations
14.
Aue, Georg, Clare Sun, Delong Liu, et al.. (2018). Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia. The Journal of Immunology. 201(7). 1967–1974. 21 indexed citations
15.
Herishanu, Yair, Ben‐Zion Katz, Nili Dezorella, et al.. (2017). Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia. Haematologica. 102(5). 874–882. 72 indexed citations
16.
Herndon, Thomas M., Nakhle S. Saba, Janet Valdez, et al.. (2017). Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia. 31(6). 1340–1347. 88 indexed citations
17.
Sun, Clare, Camilia Soof, Sarah E. M. Herman, et al.. (2017). Serum B-Cell Maturation Antigen As a Biomarker for Chronic Lymphocytic Leukemia Treated with Ibrutinib. Blood. 130. 4031–4031. 2 indexed citations
18.
Niemann, Carsten Utoft, Sarah E. M. Herman, Irina Marić, et al.. (2015). Disruption of in vivo Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study. Clinical Cancer Research. 22(7). 1572–1582. 160 indexed citations
19.
Ko, David, et al.. (2010). Outcomes of anal fistula surgery in patients with inflammatory bowel disease. The American Journal of Surgery. 199(5). 609–613. 35 indexed citations
20.
Ko, David, et al.. (2009). Anal fistula plug and fibrin glue versus conventional treatment in repair of complex anal fistulas. The American Journal of Surgery. 197(5). 604–608. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Herbaux Breakdown of academic impact, for papers by Tycel Phillips Breakdown of academic impact, for papers by Sophie de Guibert Breakdown of academic impact, for papers by Jeanette Lundin Breakdown of academic impact, for papers by P. M. Kluin Breakdown of academic impact, for papers by D Filippa Breakdown of academic impact, for papers by Michaela Cerri Breakdown of academic impact, for papers by E. Condé Breakdown of academic impact, for papers by Elisabeth Vandenberghe Breakdown of academic impact, for papers by Eugenia Haralambieva
Rankless by CCL
2026